Join MGI at Spatial Biology UK 2024
3/18/24
3/19/24
Offline
London, United Kingdom
Share
Register Now
Introduction:
MGI is delighted to announce its participation as an exhibitor at Spatial Biology UK 2024, hosted by Oxford Global. The congress will take place on March 18th-19th at Novotel London West, gathering leaders, experts, and researchers in spatial biology. Come and visit us at booth 15!
Congress Highlights:
Spatial Multi Omics Techniques & Approaches: Explore innovations in spatial multi-omics techniques and their clinical translations.
Spatial Biology in Pharma & Translational Drug Research: Discover the application of spatial biology in pharmaceutical R&D and diagnostics.
Image Analysis & Digital Pathology: Learn about AI-powered imaging and digital pathology advancements.
Applications of Spatial Research in Biology: Gain insights into spatial research applications in various fields.
Agenda at a Glance:
Day One: Spatial Multi Omics Techniques & Pharma Applications
Day Two: Spatial Bioinformatics and Imaging Innovations
What to Expect:
Engage with industry leaders and experts.
Explore cutting-edge spatial biology technologies.
Forge valuable connections and collaborations.
MGI looks forward to showcasing its latest genomics and sequencing technologies at Spatial Biology UK 2024. Visit us at booth 15 to learn more about our contributions to spatial research advancements. See you there!
Join MGI at Spatial Biology UK 2024
Register Now
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
GENOMICS RESEARCH
SPATIAL BIOLOGY
UK EVENT
Share this article :
Share
More Events
Sep 12, 2026
MGI Tech at ECP 2026: Advancing Pathology with Genomics and Proteomics
Discover MGI’s latest genomic and proteomic solutions at ECP 2026, designed to empower pathologists and researchers with new approaches to tissue and disease analysis and accelerate the transition toward more comprehensive, data-driven pathology.
Sep 28, 2026
From data to discovery: MGI showcases spatial biology use cases at ESSB 2026
Discover how spatial and single-cell technologies can turn complex tissue biology into actionable biological insight. Meet MGI at ESSB 2026 and explore our latest Stereo-seq use cases and scientific presentations.
Jun 29, 2026
Exploring the Future of Spatial Transcriptomics at STOC 2026
oin us in Milan at the STOC General Meeting together with the STOmics team. Discover the latest innovations in spatial transcriptomics, explore emerging applications in spatial biology, and connect with our experts to discuss how cutting-edge technologies can advance your research.